TERT and breast cancer: While an almost perfect agreement between the two methods was shown in the two case-control studies, we further investigated whether it was maintained in a large series of serial urine samples from follow-up BC cases (n = 394) where we expected a fraction of samples to carry low MAF TERT promoter mutations.